Pharmacokinetic Study

2

Review clinical trials related to Pharmacokinetic Study. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

This is a phase II, single-centre, pragmatic, non-randomized, dose escalation study to evaluate optimal dose levels of enzalutamide in elderly patients using pharmacokinetic blood sampling concentrations.

Participants needed: 26
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Sunnybrook Health Sciences CentreUpdated: Apr 6, 2026Locations: 1
Eligibility criteria

Male aged 75 years or older. [+11]

Metastatic castration-resistant prostate cancer [+12]

Status: Recruiting

A Phase 1 Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)

This study will evaluate the effects of a single dose of AGA2118 in Japanese, Chinese, and Caucasian participants

Participants needed: 30
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Angitia Incorporated LimitedUpdated: Jan 23, 2026Locations: 1
Eligibility criteria

Healthy males or females, aged 18 to 65 years [+2]

Participating or have participated in another clinical trial within the past 6 m... [+5]